Site Search
New tests launched in October - Insights
In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in March - Insights
In March 2023, Mayo Clinic Laboratories announced twenty nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in November - Insights
In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Gynecological cancer - Insights
Find out how our gynecological cancer panels evaluate genes with relevance to diagnosing and treating uterine, ovarian, and endometrial cancers.
Our renal diagnostics are backed by a multidisciplinary approach and an award-winning team of Mayo Clinic nephrology experts, pathologists, and laboratory scientists who work at the intersection of research and patient care.
Applying Mayo Clinic MASSFIX to Urine Samples - Insights
In this month's "Hot Topic," David Murray, M.D., Ph.D., reviews the role of urine testing for monoclonal gammopathies and discusses Mayo Clinic’s use of MASSFIX to replace traditional immunofixation testing.
A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.
Anti-hypertensive drug monitoring - Insights
Learn how Mayo Clinic Laboratories’ anti-hypertensive drug panel can assist physicians in understanding the reasons for resistant hypertension in patients.
Learn how our renal testing delivers accurate answers in concise reports that improve outlooks for patients with glomerular diseases.
Urinary stone services - Insights
Learn how our approach to kidney stone services and concise reporting enable accurate interpretation to guide clinical decisions.
Muscle and nerve biopsy consultation - Insights
Our experienced muscle and nerve specialists apply their knowledge to correlate pathological findings with clinical presentation and other testing to confirm specific neuromuscular diseases.
Neuropathy and Neuromuscular Gene Panel Update - Insights
In this month's "Hot Topic," Christopher Klein, M.D., and Zhiyv (Neal) Niu, Ph.D., discuss how Mayo Clinic’s neuropathy and neuromuscular gene panels have enhanced patient care.
Necrotizing Autoimmune Myopathy Testing - Mayo Clinic Laboratories
We offer advanced testing of the most pertinent antibodies associated with IMNM on a sensitive immunofluorescence-based assay providing fast results for patients.
An uncommon antibody, a life restored: Jori Pearson - Insights
Sophisticated laboratory testing solved a medical riddle and finally got Jori Pearson back on his feet, doing what he loves.
Patient information - Insights
Learn more about how Mayo Clinic Laboratories’ lupus testing can helping patients understand their disease activity and flare risk.
Respiratory viruses - Insights
Browse our full suite of serology and PCR testing for respiratory viruses like influenza, RSV, and more.
Case Studies in Laboratory Safety - Insights
PACE/State of FL - This webinar will provide a review of several real-life laboratory safety events. The presentation will outline the scenarios, the lessons learned and look at ways future incidents can be prevented. We will also discuss...
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
Test selection guides - Insights
Mayo Clinic Laboratories has created specialty-specific Test Selection Guides to help you find the right testing for patients quickly and easily.
Learn why liquid biopsy testing is a viable alternative to tissue-based biopsy testing for certain patients with cancer.
Find out how our suite of MayoComplete next-generation sequencing panels puts patients on the right treatment path.
Shining light on one family's struggle: Barbara, Deborah, Pamela, and Rylie - Insights
Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.
Unraveling a diagnostic mystery: Ed Garber - Insights
Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by Mayo Clinic Laboratories gave them the...
See how our unique panel includes testing for antibodies proven to be associated with paraneoplastic or cancer-associated retinopathy.
A journey to diagnosis: One patient's story of resilience and hope - Insights
For many, the path to a correct diagnosis can be long and filled with uncertainty. This story highlights the resilience and determination of one patient who navigated a complex medical journey to find answers and hope at Mayo Clinic. The...
Inborn errors of metabolism - Insights
Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can diagnose inborn errors of metabolism.
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
Regaining quality of life after a decade lost to misdiagnosis: Kelly Dubois - Insights
Misdiagnosed with acromegaly, a disease marked by too much growth hormone, and plagued by a host of mysterious health problems from unnecessary medications, Kelly DuBois finally found answers after pharmacogenomic testing from Mayo Clinic...
Malabsorption panel: Filling a gap in pediatric care - Insights
Mayo Clinic Laboratories is committed to innovation that provides the right test at the right time for the right patients. That effort always starts with identifying gaps in patient care. Filling those gaps sometimes involves not developing...
Lab discoveries fuel updates for autoimmune movement disorders test - Insights
Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...
Patients are at the heart of all we do at Mayo Clinic Laboratories. Our laboratory testing can clear the fog of an uncertain diagnosis, point to the next steps in care, and pave the way for better treatment. Our work makes a difference in...
Giving thanks for years of prostate cancer treatment: Kurt Glover-Ettrich - Insights
After immigrating to the United State and becoming a U.S. citizen at the age of 18, Holocaust survivor Kurt Glover-Ettrich chose to give back to his new homeland by serving a 30-year career in the U.S. military. Today, as a Mayo Clinic...
Testing for systemic lupus erythematosus (SLE) and related antiphospholipid syndrome (APS) at Mayo Clinic Laboratories is performed by experienced laboratory scientists and testing experts with decades of experience diagnosing autoimmune...
Answers to the most commonly asked questions on shipping supplies and requirements, turn-around-times, and billing, among others.
Hereditary hearing loss - Insights
Learn how our hereditary hearing loss test can help avoid unnecessary workups and appointments and reduce anxiety for patients and their families.
Hereditary epilepsy - Insights
Find out how we perform in-depth mutation and copy number variant analysis to determine causes of epilepsy and identify potential treatment options.
Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme, alpha-L-iduronidase (IDUA), which...
Learn about our hereditary cancer test offerings, including single-gene assays that evaluate specific genes already identified in a parent.
Find out how our sarcoma panel assesses gene mutations and fusions described in more than 50 types of soft tissue, bone, and other mesenchymal tumors.
Learn how our pediatric neuro-oncology testing includes both comprehensive MayoComplete next-generation sequencing and chromosomal microarray.
Biopharma solutions - Insights
Inspired by Mayo Clinic’s tradition of collaboration to break down barriers, expand knowledge, and change medicine, BioPharma Diagnostics brings unmatched expertise and quality to each project. Whether supporting clinical trials, advancing...
Mosquito-borne disease - Insights
View our comprehensive menu of individually orderable tests and panels for mosquito-borne diseases and our algorithmic approach to testing.
Familial Variant Targeted Testing (FMTT) - Insights
In this month's "Hot Topic," Megan Hoenig, M.S., M.P.H., CGC, a licensed and certified genetic counselor with the Division of Laboratory Genetics and Genomics at Mayo Clinic Laboratories, describes the principles and benefits of Familial...
In vitro diagnostics solutions - Insights
BioPharma Diagnostics supports medical device, biopharma, and diagnostic companies with in vitro diagnostic services, including analytical validation of new assays and devices in compliance with CAP/CLIA requirements.
Pharmaceutical solutions - Insights
We believe the pharmaceutical industry and clinical research partners can improve global health through innovative drug discovery and development — and that you deserve the best reference lab partner at your side. Mayo Clinic BioPharma...
Effective testing is vitally important for diagnosis, prognosis, and disease management. With more than 90% of the 7,000 identified rare diseases lacking FDA-approved treatment,1 and patients waiting between 8 and 10 years before diagnosis,...
Learn about our sponsored testing program and how it can benefit both patients and healthcare providers.
Research collaborations - Insights
Find out about setting up a contract with Mayo Clinic, analytical validation, the role of the institutional review board, and how your data will be handled.
For children who require thiopurine medications (such as azathioprine and 6-mercaptopurine) to treat inflammatory bowel disease (IBD), understanding how thiopurines are metabolized is vital to choosing the most effective treatment. Because...